Analysts expect Resmed Inc to report revenue of 1.35 B for Q1 27, against a range of 1.28 B to 1.42 B. The most recent reported quarter, Q4 26, came in at 1.46 B, a 4.6% beat against the 1.40 B consensus.
| Metric | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 | Q1 31 | Q2 31 | Q3 31 | Q4 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.22 B | 1.28 B | 1.29 B | 1.35 B | 1.34 B | 1.42 B | 1.43 B | 1.46 B | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 1.33 B | 1.47 B | 1.42 B | 1.34 B | 1.50 B | 1.37 B | 1.60 B | 1.50 B | 1.42 B | 1.62 B | 1.50 B | 1.50 B | 1.51 B | 1.62 B | 1.75 B | 1.82 B | ||||||||||||
| Low Estimate | 1.12 B | 1.23 B | 1.33 B | 1.24 B | 1.26 B | 1.28 B | 1.34 B | 1.29 B | 1.28 B | 1.39 B | 1.23 B | 1.33 B | 1.38 B | 1.39 B | 1.59 B | 1.56 B | ||||||||||||
| Consensus Estimate | 1.23 B | 1.35 B | 1.38 B | 1.29 B | 1.38 B | 1.33 B | 1.47 B | 1.40 B | 1.35 B | 1.51 B | 1.36 B | 1.41 B | 1.45 B | 1.51 B | 1.67 B | 1.69 B |
Analysts expect Resmed Inc to report earnings per share of 12.87 for 2027, against a range of 12.47 to 13.27. The most recent reported year, 2026, came in at 11.17, a 2.9% beat against the 10.85 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 5.79 | 6.44 | 7.72 | 9.55 | 11.17 | - | - | ||
| High Estimate | 6.04 | 7.44 | 8.19 | 9.40 | 11.86 | 13.27 | 15.38 | ||
| Low Estimate | 5.64 | 6.34 | 6.71 | 8.34 | 9.84 | 12.47 | 12.86 | ||
| Consensus Estimate | 5.84 | 6.89 | 7.45 | 8.87 | 10.85 | 12.87 | 14.12 |